Respiration Disorders

Merck Makes $10B Acquisition of Verona Pharma to Bolster Respiratory Portfolio

2 weeks ago talkbio0Tagged Acquisition, COPD, Drug Industry, Keytruda patent, Merck, Ohtuvayre, Pharma, Respiration Disorders, Verona

Merck; Verona Pharma; acquisition; Ohtuvayre; COPD; respiratory disease; Keytruda patent; biotech; pharmaceutical industry

AstraZeneca’s IL-33 Drug Shows Mixed Results in COPD Trials, Despite Phase 2 Setbacks

11 months ago talkbio0Tagged AstraZeneca, Chronic Obstructive Airway Disease, IL33 protein, human, Phase 2 Trials, Respiration Disorders, Tozorakimab

AstraZeneca, IL-33, COPD, tozorakimab, phase 2 trials, respiratory diseases

GSK Partners with Flagship Pioneering to Develop 10 Novel Medicines and Vaccines

12 months ago talkbio0Tagged bioplatform companies, Drug Discovery, Flagship, Immunology, Partnership, Pfizer, Pioneering, Respiration Disorders, RNA, Messenger, SmithKline Beecham, Vaccines

GSK, Flagship Pioneering, drug discovery, vaccines, respiratory disease, immunology, bioplatform companies, mRNA vaccines, Pfizer, biotech partnership